Jacobs Levy Equity Management, Inc Corcept Therapeutics Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,223,781 shares of CORT stock, worth $67.1 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,223,781
Previous 870,834
40.53%
Holding current value
$67.1 Million
Previous $28.3 Million
100.09%
% of portfolio
0.23%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding CORT
# of Institutions
339Shares Held
86.5MCall Options Held
1.27MPut Options Held
454K-
Black Rock Inc. New York, NY16.5MShares$906 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$548 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$453 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$357 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$209 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.87B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...